57 participants
Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-07-18
- Start Date:
- 2009-03-31
- Completion:
- 2013-01-31
Conditions
- Chronic Myeloid Leukemia
Interventions
- DRUG
No Results Yet